Astellas Pharma and Medivation have announced the submission of marketing authorization application (MAA) to the European Medicines Agency (EMA) for enzalutamide to treat metastatic castration-resistant prostate cancer in men who have ...
Tags: enzalutamide, metastatic castration-resistant prostate cancer
Health Canada has permitted Trimel Pharmaceuticals' to enroll patients in Canada for the Tefina Phase II Ambulatory study. The double-blinded, placebo-controlled study will enroll 240 pre-menopausal women patients with female orgasmic ...
Tags: Trimel, Tefina, female orgasmic disorder
Auxilium Pharmaceuticals and FCB have filed a patent infringement lawsuit, related to Testim 1% testosterone gel, against Watson Laboratories, Watson Pharmaceuticals, and Watson Pharma. The lawsuit was filed in the US District Court ...
Tags: patent infringement lawsuit, Watson, generic product, FDA
Medivation and Astellas Pharma have announced the submission of new drug application (NDA) for enzalutamide (formerly MDV3100) to the FDA. The enzalutamide has been studied in patients with castration-resistant prostate cancer who ...
Tags: enzalutamide, new drug application, pharmaceutical product
For all our mutual attraction and eternal adulation,men and women still require and seek time alone from one another.Women,who have tended to form emotionally stable relationships with other women all their lives,and revel in the ...
Tags: patio, new man cave, construction